(Q52602412)

English

Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors.

scientific article published in January 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

0 references

1 reference

based on heuristic

inferred from title

author name string

Birnbaum J

1

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Ramadour M

2

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Magnan A

3

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Vervloet D

4

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Clinical & Experimental Allergy

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

33

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

1

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

58-64

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Regimens of Hymenoptera venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01564.X

21 January 2018

Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01564.X

21 January 2018

Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01564.X

21 January 2018

Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2003.01564.X

21 January 2018

Identifiers

10.1046/J.1365-2222.2003.01564.X

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 May 2018

http://europepmc.org/abstract/MED/12534550

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52602412&oldid=1364132852"